Quality Systems sees double-digit gains in Q2

Justine Varieur Cadet | | Health Imaging | Artificial Intelligence
Quality Systems, the parent company of EHR developer NextGen Healthcare, has reported double-digit gains for net income and net reviews among results of operations for its fiscal 2011 second quarter, which ended Sept. 30.

The company reported record net revenues of $81.5 million for the fiscal 2011 second quarter, an increase of 14 percent from $71.7 million in the comparable period last year.

The Irvine, Calif.-based Quality Systems also reported net income of $13.4 million for 2011 second quarter, a 14 percent increase when compared with $11.8 million in net income for the same period last year.

“Now that we have met both meaningful use and Certification Commission for Healthcare Information Technology (CCHIT) standards, we believe our ... product and service offering will bode well for those physicians and hospitals seeking to transition to EHR and help to optimize shareholder value as we enter year one of the five-year stimulus plan,” said Steven T. Plochocki, Quality Systems’ chief executive officer.

Justine Varieur Cadet

Related Content

Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
ACR Assess-AI national data registry tracks performance of clinical algorithms
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.